Methods for inhibiting myostatin activation by administering anti-pro/latent myostatin antibodies
US10882904B2 · kind B2 · utility
4Cited by
7References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 21, 2019 |
| Grant date | Jan 5, 2021 |
| Priority date | — |
| Expiry date | Mar 21, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to antibodies that specifically bind pro-myostatin and/or latent myostatin, and methods and uses thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.